Search for: "United States of America v. Johns" Results 261 - 280 of 1,979
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Oct 2021, 1:07 pm by David Kopel
Supreme Court considers whether to enforce the Second Amendment right to "bear arms" in New York State Rifle & Pistol Association v. [read post]
11 Oct 2021, 6:04 am by Florian Mueller
It is in the national economic (and also the national security) interest of the United States to encourage manufacturing companies to invest. [read post]
6 Oct 2021, 10:26 am by Howard Bashman
Supreme Court has posted online the transcript and audio of oral argument in United States v. [read post]
3 Sep 2021, 5:01 am by Peter Margulies
In addition, access to counsel was far more difficult from Mexico than it is in the United States, where accessing counsel is difficult enough. [read post]
29 Aug 2021, 9:01 pm by Neil H. Buchanan
And it is worth remembering that the John Lewis Act had seemed to be the bill most likely to receive at least some Republican support, because it mostly tries to restore the status quo ante that the Supreme Court’s conservative majority destroyed in Shelby County v. [read post]
13 Aug 2021, 4:00 am by Jim Sedor
End Citizens United had alleged Scott and the New Republican PAC, a group he formerly chaired, violated election laws prohibiting coordination between candidates and outside groups. [read post]
23 Jul 2021, 11:20 am by admin
Brach filed on behalf of Frederick LeGrande, against Johns-Manville, for asbestos-related disease, on July 17, 1957, in LeGrande v. [read post]
22 Jul 2021, 9:08 pm by Omar Khodor
Patent and Trademark Office updated its guidance related to the recent United States v. [read post]
15 Jul 2021, 2:54 pm by Kevin LaCroix
In its June 21, 2021 decision in Goldman Sachs Group, Inc. v. [read post]
13 Jul 2021, 10:58 am by Simon Lester
In the United States (US), as for most developed countries,[6] trade policy and IP standards have consistently been linked, a pattern which can (at least partially) be traced back to extensive lobbying by senior management at US-based technology and pharmaceutical firms.[7] For example, since at least the 1980s, Pfizer Inc. has been involved in mobilizing other US firms and stakeholders to lobby US policymakers on the issue of international IP protection. [read post]